Published in Vaccine Weekly, October 2nd, 2002
The patent, United States Patent Number 6,413,935 entitled, "Induction of Immune Response Against Desired Determinants," includes claims covering the induction of immune responses using the company's PADRE technology combined with disease-specific antigens. The patent also includes claims addressing different types of disease-specific antigens including proteins,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly